Ligand Pharmaceuticals Inc (LGND)
Operating Expenses
$185.49M
TTM · Period ending: · USD
LGND Operating Expenses
Latest reported$185.49Mperiod ending
Latest reported$185.49Mperiod ending
LGND Operating Expenses ($9.50M → $185.49M)
Annual operating expenses
High-resolution chart · PNG
LGND operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 214,300,500 | |
| 178,665,000 | |
| 84,323,000 | |
| 140,381,000 | |
| 75,517,000 | |
| 95,643,000 | |
| -698,141,000 | |
| 81,389,000 | |
| 67,660,000 | |
| 58,485,000 | |
| 37,758,000 | |
| 34,692,000 | |
| 27,258,000 | |
| 26,898,000 | |
| 25,268,000 | |
| 51,790,000 | |
| 70,316,000 | |
| 52,591,000 | |
| 73,069,000 | |
| 287,088,000 | |
| 163,232,000 | |
| 161,079,000 | |
| 128,700,000 | |
| 100,485,000 | |
| 85,531,000 | |
| 92,374,000 | |
| 94,100,000 | |
| 95,000,000 | |
| 92,300,000 | |
| 79,100,000 | |
| 53,100,000 | |
| 9,500,000 |